Scientists have described the drug trial of an experimental mRNA vaccine for melanoma as a possible shift in treatment options. This study began on August 23, 2026, at 5:00 a.m. EDT. Recently, at 73, Mark Orwig, who coaches tennis in the San Francisco Bay Area, participated in this trial. He, along with other skin cancer patients worldwide, tested this innovative cancer vaccine made with messenger RNA.
Orwig faced melanoma in 2023 and underwent surgery to remove a tumor from his cheek. Despite the success of the surgery, his concern persisted. Often, tiny traces of the malignant skin cancer remain in the body, posing a risk for recurrence. This challenge underscores the need for effective post-surgery treatment strategies.